Provectus Biopharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Provectus Biopharmaceuticals, Inc.‘s stocks are currently a part of 5 hedge funds’ portfolios, which represents 0.05% of the total amount of its stocks outstanding. This makes up a total of 218.62K shares of Provectus Biopharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -3.38% or -7.65K shares fewer.
Hedge funds holding Provectus Biopharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 3 |
|---|---|
| Q3 2018 | 5 |
| Q4 2018 | 4 |
| Q1 2019 | 4 |
| Q2 2019 | 3 |
| Q3 2019 | 3 |
| Q4 2019 | 2 |
| Q1 2020 | 2 |
| Q2 2020 | 4 |
| Q3 2020 | 4 |
| Q4 2020 | 5 |
| Q1 2021 | 6 |
| Q2 2021 | 6 |
| Q3 2021 | 7 |
| Q4 2021 | 6 |
| Q1 2022 | 6 |
| Q2 2022 | 6 |
| Q3 2022 | 6 |
| Q4 2022 | 6 |
| Q1 2023 | 5 |
Hedge funds changes in Provectus Biopharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 1 | 0 | 0 | 2 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 0 | 0 | 0 | 3 |
| Q4 2018 | 0 | 0 | 0 | 1 | 3 |
| Q1 2019 | 1 | 0 | 0 | 1 | 2 |
| Q2 2019 | 0 | 0 | 0 | 1 | 2 |
| Q3 2019 | 0 | 0 | 0 | 0 | 3 |
| Q4 2019 | 0 | 0 | 0 | 1 | 1 |
| Q1 2020 | 0 | 0 | 0 | 0 | 2 |
| Q2 2020 | 3 | 0 | 0 | 1 | 0 |
| Q3 2020 | 1 | 0 | 0 | 1 | 2 |
| Q4 2020 | 1 | 0 | 0 | 0 | 4 |
| Q1 2021 | 1 | 1 | 0 | 0 | 4 |
| Q2 2021 | 0 | 0 | 0 | 0 | 6 |
| Q3 2021 | 1 | 1 | 0 | 0 | 5 |
| Q4 2021 | 1 | 1 | 0 | 2 | 2 |
| Q1 2022 | 0 | 0 | 2 | 0 | 4 |
| Q2 2022 | 1 | 1 | 0 | 1 | 3 |
| Q3 2022 | 1 | 0 | 0 | 1 | 4 |
| Q4 2022 | 1 | 0 | 1 | 1 | 3 |
| Q1 2023 | 0 | 0 | 0 | 0 | 5 |
Top 50 hedge fund holders of Provectus Biopharmaceuticals, Inc. (OTC:PVCT)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE | 5K | 100K | 0.002% |
| DIVERSIFIED TRUST CO | 2K | 50K | 0.000% |
| LEE DANNER & BASS INC | 2K | 50K | 0.000% |
| LBMC INVESTMENT ADVISORS, LLC | 1K | 22K | 0.000% |
| ACADEMY CAPITAL MANAGEMENT INC/TX | 1K | 20K | 0.000% |
| ANCORA ADVISORS, LLC | 1K | 14.65K | 0.000% |